Kezar Life Sciences Inc (NASDAQ:KZR)

9.27
Delayed Data
As of Jul 01
 +1.00 / +12.09%
Today’s Change
4.31
Today|||52-Week Range
18.55
-44.56%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$367.3M

Company Description

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.

Contact Information

Kezar Life Sciences, Inc.
4000 Shoreline Court
South San Francisco California 94080
P:(650) 822-5600
Investor Relations:

Employees

Shareholders

Other institutional46.64%
Mutual fund holders31.91%
Individual stakeholders23.35%

Top Executives

John FowlerChief Executive Officer & Director
Christopher J. KirkPresident, Director & Chief Scientific Officer
Michael WolfeDirector-Finance & Business Operations
Marc L. BelskyChief Financial Officer & Secretary
Noreen Roth HenigChief Medical Officer